top of page

Viral Encephalitis

Background

Clinically relevant involvement of the central nervous system (CNS) by viruses is an uncommon event, considering the overwhelming number of individuals affected by the different human viral infections. Most commonly, clinically relevant viral encephalitis affects children, young adults, or elderly patients, but the spectrum of involvement depends on the specific viral agent, host immune status, and genetic and environmental factors. [1, 2] The term “acute viral encephalitis” is used to describe restricted CNS involvement (ie, involvement of the brain, sparing the meninges); however, most CNS viral infections involve the meninges to a greater or lesser extent, leading to aseptic meningitis or causing mild meningoencephalitis rather than pure encephalitis. In addition to acute viral encephalitis, other less established and more unusual manifestations of viral infections include progressive neurologic disorders, such as postinfectious encephalomyelitis (such as may occur after measles or Nipah virus encephalitis) and conditions such as postpoliomyelitis syndrome, which has been considered by some to be as a persistent manifestation of poliovirus infection. Provocative studies have found high antibody seroprevalence to viruses such as Ebola, Marburg, and Lyssa viruses in multiple African countries, indicating the presence of a high number of undiagnosed cases every year, including high neutralizing titers of antibodies to rabies virus in 11% of a small cohort of asymptomatic Peruvians living in the Amazon with prior exposure to bats. These studies raise the possibility that in some populations, those conditions may be more common than previously recognized. [3] The emergence of new types of viral infections, such as the Toscana virus (in the Western European countries located on the northern border of the Mediterranean sea, Cyprus and Turkey) where seropositivity in the population is not matched by clinical symptoms (indicating that most infections are mild) also highlight the fact that we need to be alert about the possible threats from unknown pathogens, even in areas that are not necessarily tropical or surrounded by rain forests. An unusual CNS involvement leading to microcephaly due to infection of pregnant women by Zika virus has also been recently reported and highlights the constant need to look for new types of neurological manifestations of viral infections in humans. [4] This article is a general overview of the most common viral encephalitides and provides details about general workup and treatment for these important conditions. More detailed descriptions of each viral family are provided elsewhere.


See the following:


Pathophysiology

The initial event in the replicative cycle of a virus is its interaction with receptors present on the surface of a cell. Knowledge of this interaction is important in understanding viral spread, tropism, and pathogenesis. The following cellular receptors have been described for these viruses (see Table 1, below):


Despite viral tropism, the pattern of distribution of lesions in the brain is rarely specific enough to permit identification of the infecting virus. Recent studies have reported a Mendelian predisposition to some forms of encephalitis (especially herpes simplex encephalitis) due to defects in the following pathways: TLR-3 interferon, autosomal recessive STAT-1 deficiency and X-linked NEMO deficiency, UNC-93B deficiency, and autosomal dominant TLR3 deficiency. [7] The pathophysiology of viral encephalitis varies according to the viral family. Viruses enter the CNS through 2 distinct routes: (1) hematogenous dissemination and (2) retrograde neuronal dissemination. Hematogenous dissemination is the more common path. Humans are usually incidental terminal hosts of many viral encephalitides. Arbovirus encephalitides are zoonoses, with the virus surviving in infection cycles involving biting arthropods and various vertebrates, especially birds and rodents. The virus can be transmitted by an insect bite and then undergoes local replication in the skin. Transient viremia leads to seeding of the reticuloendothelial system and muscles. After continuous replication, secondary viremia leads to seeding of other sites, including the CNS. In fatal cases, little histopathologic change is noted outside the nervous system. St. Louis encephalitis is an exception, in that renal involvement is occasionally present. On gross examination, variable degrees of meningitis, cerebral edema, congestion, and hemorrhage are observed in the brain. Microscopic examination confirms a leptomeningitis with round-cell infiltration, small hemorrhages with perivascular cuffing, and nodules of leukocytes or microglial cells. Demyelination may follow the destruction of oligodendroglias, and involvement of ependymal cells may lead to hydranencephaly. Neuronal damage is seen as chromatolysis and neuronophagia. Areas of necrosis may be extensive, especially in eastern equine encephalitis (EEE) and Japanese encephalitis (JE). Recent experimental evidence has shown that arboviruses can induce apoptotic cell death in neurons in the brains of their hosts. Patients who survive the initial illness associated with viral encephalitis feature varying degrees of repair, which may include calcification in children. Retrograde neural dissemination is the main route of spread for several important viral pathogens. Rabies virus usually spreads to the CNS through retrograde peripheral nerve dissemination. This virus tends to exhibit tropism for the temporal lobes, affecting the Ammon horns. One of the possible routes of CNS spread for herpes simplex virus (HSV) is through the olfactory tracts. Herpesviruses have tropism for the temporal cortex and pons, but the lesions may be widespread. Herpes simplex encephalitis (HSE) in infants is usually part of a widespread infection that produces focal necrotic lesions with typical intranuclear inclusions in many organs. In adults and in some children, lesions are confined to the brain. Necrotic foci may be macroscopically evident as softening. Inclusion bodies are found readily in the margins of areas of necrosis; focal perivascular infiltration and neuronal damage are evident. In addition to the direct effect of the viral pathogen, acute encephalopathy may be associated with viral infections and increased plasma concentrations of chemokine (CXC motif) ligand 8 (CXCL8; interleukin [IL]-8), chemokine (C-C motif) ligand 2 (CCL2; monocyte chemotactic protein-1 [MCP - 1]), IL-6, and CXCL10 (interferon gamma–induced protein 10 kd [IP-10], without viral neuroinvasion (hyperactivated cytokine response). Accordingly, it is important to differentiate encephalitis from encephalopathy as a disruption of brain function that is not related to a direct structural or inflammatory process. To illustrate the difficulty of making this distinction in daily clinical practice, until recently it was not clear whether encephalopathy after dengue fever infection was due to direct CNS invasion or to viremia. Studies have now documented the presence of IgM and IgG for dengue virus in the cerebrospinal fluid (CSF) of patients with dengue fever and neurologic manifestations.

Etiology

HSE is the most common form of encephalitis in the United States (see Herpes Simplex Encephalitis). Human herpesvirus (HHV)-6, the causative agent of exanthema subitum, has been associated with a wide spectrum of neurologic complications, including viral (focal) encephalitis. Numerous other viruses are known to cause encephalitis (see Tables 2 and 3 below). The viruses most commonly associated with acute childhood encephalitis are mumps virus, measles virus, and varicella-zoster virus (VZV). Table . Common Viral Encephalitides:


Virus (Family)

Viral Structure

Transmission

Mortality

Specific Clinical Patterns

Sequelae

Season

HSV (herpesvirus)

ds DNA

Unknown

70% if untreated

Rare forms: subacute, psychiatric, opercular, recurrent meningitis HSV-1: brainstem; HSV-2: myelitis

Common

All year

VZV (herpesvirus)

ds DNA

Direct contact (air)

Variable, low in children

Rash, encephalitis in 0.1-0.2% of children with chickenpox; cerebellar ataxia (cerebellitis)

Adults worse; cerebellitis good

Late winter, spring

Influenza virus (orthomyxovirus)

ss RNA

Direct contact (air), highly contagious

Unknown

Reversible frontal syndrome in children; Guillain-Barré, myelitis

Parkinsonism (encephalitis lethargica)

Usually winter

Enteroviruses (picornavirus)

ss RNA

Fecal-oral route

Low; high for enterovirus 71Herpangina; hand, foot, mouth disease; enterovirus 71 causes rhombencephalitis

Mild, except for enterovirus 71

Summer, fall; tropics: no season

​

Rabies virus (rhabdovirus)

ss RNA

Dogs, wild animals (eg, fox, wolf, skunk)

Virtually 100%

Paresthesias; confusion, spasms, hydrophobia; brainstem features

Mortality virtually 100%

All year

ds—double strand; HSV—herpes simplex virus; ss—single strand; VZV—varicella-zoster virus. Arthropod-borne viruses (arboviruses) are important causes of encephalitis worldwide. More than 20 arboviruses that can cause encephalitis have been identified. These arboviruses are enveloped RNA viruses from different families: Togaviridae (genus Alphavirus), Flaviviridae (genus Flavivirus), Bunyaviridae (genus Bunyavirus), and Reoviridae (see Table 4 below). Important encephalitides caused by alphaviruses include EEE, western equine encephalitis (WEE), and Venezuelan equine encephalitis (VEE). EEE is endemic along the eastern and Gulf coasts of the United States, in the Caribbean region, and in South America. North American strains produce a fulminant disease (50-75% mortality) with a high incidence of neurologic sequelae. WEE is most common in the western and midwestern United States but has a lower mortality rate (10%) than EEE. VEE occurs in South America and Central America as well as in the southwestern United States, typically causing mild disease and, rarely, neurologic impairment. Flaviviruses are transmitted by ticks and mosquitoes and are found worldwide. The most common form of flavivirus is the Japanese B encephalitis virus. This flavivirus is one of the most important causes of viral encephalitis worldwide, with 50,000 new cases and 15,000 deaths annually. It has been found in China, Southeast Asia, the Indian subcontinent, the Philippines, New Guinea, Guam, and Australia. West Nile virus is a flavivirus similar to the Japanese B virus. Its life cycle occurs between birds and mosquitoes. Culex mosquitoes, Anopheles mosquitoes, and Aedes mosquitoes are the primary vectors to humans. West Nile virus is endemic in Africa, the Middle East, Russia, India, Indonesia, and parts of Europe. It was detected for the first time in the Western hemisphere during an outbreak of encephalitis in the summer of 1999 in New York City (see West Nile Encephalitis). [8, 9] Dengue fever is the most important arboviral infection of humans, with 100 million cases per year. It can now be seen in any country between the tropics of Capricorn and Cancer (placing an estimated 2.5 billion people at risk). Until recently, dengue fever was considered to be uncommonly associated with neurologic manifestations (except when dengue hemorrhagic fever is present). However, this view has changed; in endemic areas, dengue fever may be one of the most common forms of viral encephalitis. [10, 11, 12] It is important to emphasize that the geographic distribution of dengue virus has increased. In 2009, locally acquired disease was diagnosed in New York City and subsequently in Key West in Florida (no locally acquired disease had been reported in the US since 1945). Before the 1999 outbreak of West Nile encephalitis (WNE), St Louis encephalitis was the most common disease caused by a flavivirus in the United States. Outbreaks of St Louis encephalitis occur from August to October throughout the country. Individual susceptibility to the St Louis virus increases with age, and encephalitis can be accompanied by hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Mortality is age related, ranging from 2-20%, and sequelae are present in 20% of survivors. Other important flaviviral diseases include Far East tick-borne encephalitis (former eastern Russia), Central European tick-borne encephalitis (Central Europe), [13] and Powassan encephalitis (Canada and northern United States). [14] Bunyaviruses are the largest group of arboviruses and include the viruses that cause La Crosse encephalitis, Jamestown Canyon encephalitis, and California encephalitis (CE). La Crosse virus is the most common cause of arboviral encephalitis in the United States and produces seizures and focal neurologic signs, manifested primarily in children, with a mortality of less than 1% and rare sequelae. [15] Toscana virus was identified in Central Italy in 1971. It has a larger geographic distribution over the northern border of the Mediterranean Sea, including Cyprus and Turkey. Most affected individuals are not symptomatic or mildly symptomatic, although severe cases of meningitis and meningo-encephalitis have been reported. Orbivirus is transmitted by the tick Dermacentor andersoni and is seen in the Rocky Mountains of the United States. Retroviruses are also a cause of encephalitis. Human T-cell lymphotrophic virus type 1 (HTLV-I) is associated predominantly with spastic paraparesis, not with causing encephalitis. Certain forms of encephalitis are observed almost exclusively in patients with HIV. Among those, cytomegalovirus (CMV) ventriculoencephalitis has emerged as a unique entity in patients with advanced HIV infection. Measles and mumps viruses (paramyxoviruses) can also cause neurologic disease. Measles typically does not cause encephalitis in the acute phase, but 1 in 1000 cases can give rise to postinfectious autoimmune syndrome (ie, SSPE). Nipah virus (Paramyxoviridae family) was first detected after an outbreak of encephalitis in pig farmers in Malaysia. Nipah virus is a zoonosis and infects pigs. Subsequent outbreaks occurred in several countries in South Asia, including Bangladesh (2001 and 2003). [16] Arenaviruses usually infect rodents. Thus, lymphocytic choriomeningitis most commonly occurs during the winter, when mice are indoors and humans have contact with their excreta. Meningitis or meningoencephalitis follows a 5- to 10-day incubation period. Recovery can be prolonged but is usually complete. Lassa fever is a West African disease that starts with gastrointestinal (GI) and respiratory complaints and progresses to hemorrhagic shock. Unilateral or bilateral deafness may follow the period of encephalitis. Mortality is in the range of 8-52%. Enteroviruses are picornaviruses. The Picornaviridae family includes coxsackievirus A and B, poliovirus, echovirus, enterovirus (EV) 68 and 71, and hepatitis A virus (HAV). Enteroviruses are transmitted by the fecal-oral route, and CNS spread is through the hematogenous route. Infection is most common in summer and early fall. In 2014, the United States experienced a nationwide outbreak of EV-D68 associated with severe respiratory illness. From mid-August 2014 to January 15, 2015, CDC or state public health laboratories confirmed a total of 1,153 people in 49 states and the District of Columbia with respiratory illness caused by EV-D68. Almost all of the confirmed cases were among children, many whom had asthma or a history of wheezing. [17] One study reports that EV-D68 inhibits innate antiviral immunity by downregulation of interferon regulatory factor 7 (IRF7). [18] Outbreaks of enterovirus 71 have occurred in Japan, Malaysia, and Taiwan. Enterovirus 71 is typically associated with hand-foot-and-mouth disease, but up to 30% may develop neurological manifestations. In 2012, a severe encephalitis outbreak in Cambodia, with a 69% mortality rate in children, was secondary to enterovirus 71 serotype C4. The disease mainly affected children aged 3 years and younger. Rabies is an important pathogen in developing countries, where endemic canine infection still exists. In Europe and the United States, rabies is present in wild animals (eg, skunks, foxes, raccoons, bats); however, it is controlled in domestic animals with vaccination. Rabies usually incubates for 20-60 days but can incubate for years. In a 2007 outbreak of Chikungunya virus infection in Italy, 1 elderly patient developed encephalitis and died. [19] This reinforces the risk of new outbreaks of newer forms of encephalitis in Europe and other parts of the world. [20] Recent outbreaks of Zika virus in Brazil led to the development of CNS malformations in newborns of infected pregnant women, especially due to microcephaly. [21]

Frequency

The annual incidence of viral encephalitis is most likely underestimated, especially in developing countries, because of problems with pathogen detection. [22] In a study from Finland, the incidence of viral encephalitis in adults was 1.4 cases per 100,000 persons per year. [23]

Epidemiology

The annual incidence of viral encephalitis is most likely underestimated, especially in developing countries, because of problems with pathogen detection. [22] JE affects at least 50,000 individuals per year. In a study from Finland, the incidence of viral encephalitis in adults was 1.4 cases per 100,000 persons per year. [23] HSV was the organism most frequently identified as the cause (16%), followed by VZV (5%), mumps virus (4%), and influenza A virus (4%). Age-, sex-, and race-related demographics Children and young adults are typically the groups that are most often affected. However, severity is usually more pronounced in infants and elderly patients. [24] The clinical course in children may be considerably different from that seen in adults. HSE may be associated with a relapse in 25% of the cases, which may present as a movement disorder, most often choreoathetosis. [25] Mumps meningoencephalitis affects men more often than women. Men working in areas infested by infected mosquitoes have a higher incidence of arboviral infections. No racial predilection exists, although different genetic factors may predispose individuals to more severe forms of CNS involvement.

Prognosis

The mortality depends largely on the etiologic agent of the encephalitis. The severity of sequelae apparently varies according to the causative virus as well. [26] The average lifetime cost of the sequelae of encephalitis approaches US$3 million. HSE carries a mortality of 70% in untreated patients, with severe sequelae among survivors. After WEE, sequelae are uncommon in adults but are frequent in children. Recurring convulsions with motor or behavioral changes affect more than half of children who are infected when younger than 1 month. With EEE, most adults older than 40 years who survive (10% mortality) do so unscathed; children younger than 5 years have crippling sequelae consisting of mental retardation, convulsions, and paralysis. Permanent sequelae after St. Louis encephalitis are uncommon, except for elderly individuals; the mortality rate is 2% in young adults and 20% in elderly patients. A large number of cases of newborns with microcephaly has been reported in pregnant women infected by Zika virus. [4] La Crosse virus causes a relatively mild encephalitis with a low fatality rate. Mortality is low in VEE, CE, and encephalitis due to Colorado tick fever virus. Neurologic sequelae in these conditions are not frequent and are usually mild. JE has a mortality of almost 50% in patients older than 50 years and a mortality rate of less than 20% in children. The Far East form of tick-borne encephalitis is more severe than the Central European form of tick-borne encephalitis, with mortalities as high as 20% and frequent sequelae. Epilepsia partialis continua may develop during the convalescent period or later. Residual weakness may also be present. The 20-year risk of developing an unprovoked seizure is 22% for patients with viral encephalitis associated with early seizures and 10% for viral encephalitis without early seizures. Of patients with CNS infection, 18-80% develop epilepsy, which is usually refractory to medical treatment. A considerable number of such patients develop unilateral mesial temporal lobe epilepsy and can have a good outcome after surgery. [27]


Clinical Presentation

History Viral encephalitis is usually marked by acute onset of a febrile illness. Patients with viral encephalitis generally experience signs and symptoms of leptomeningeal irritation (eg, headache, fever, neck stiffness). Patients with viral encephalitis also develop focal neurological signs; seizures [28] ; and alteration of consciousness, starting with lethargy and progressing to confusion, stupor, and coma. Behavioral and speech disturbances are common. Abnormal movements can be seen but are rare. Involvement of the hypothalamic/pituitary axis can lead to hyperthermia or poikilothermia. Symptoms associated with specific viral infections Specific clues taken from the patient’s history depend on the viral etiology. Clinical findings reflect disease progression according to viral tropism for different central nervous system (CNS) cell types. Atypical presentations include a reversible frontal lobe and limbic syndrome without disturbances of consciousness or motor function. These presentations have been described in children with influenza virus infection. [29, 30] Herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) encephalitis have subacute forms, presenting with a psychiatric syndrome and an anterior opercular syndrome, known as benign recurrent meningitis. HSV-1 encephalitis may produce a brainstem encephalitis, and HSV-2 encephalitis may also produce a myelitis. West Nile encephalitis (WNE) is usually asymptomatic in areas of endemic disease. In symptomatic individuals, an influenzalike illness occurs after incubation of 3-15 days; CNS involvement occurs in less than 15% of cases. Severe neurologic infection is more common when the virus is introduced in an area of nonendemic disease. [31, 32] In 1999, during the New York City outbreak of West Nile virus infection, 62 patients developed encephalitis, and 7 died (a case fatality rate of 12%, with all deaths occurring in older patients). Axonal neuropathy, demyelinating polyneuropathy similar to that seen in Guillain-Barré syndrome, encephalitis with and without muscle weakness, and aseptic meningitis were described. Delayed weakness or recurrent clinical weakness after West Nile virus infection has been described. [33] Japanese encephalitis (JE) typically affects children and young adults. Older adults are affected in epidemics. The clinical presentation includes a nonspecific prodrome and frequent seizures. [28] Dengue fever [34] classically presents with a severe influenzalike illness or dengue hemorrhagic fever. Less commonly, dengue fever can lead to encephalitis or encephalopathy, transverse myelitis, and mononeuropathy or polyneuropathy similar to that in Guillain-Barré syndrome. The hemorrhagic form may also cause hepatic failure leading to a Reye syndrome–like illness. Enteroviral encephalitis is usually associated with a good prognosis. However, enterovirus 71 has a high mortality and can present with herpangina or enteroviral hand, foot, and mouth disease. Complications include myocarditis and acute flaccid paralysis. Enterovirus 71 can cause a chronic meningoencephalitis in patients who are immunocompromised. Mumps encephalitis typically starts 3-10 days after parotitis and usually resolves without sequelae, except for occasional hydrocephalus due to ependymal cell involvement. Measles does not usually cause acute encephalitis. Rabies virus usually incubates for 20-60 days but is capable of incubating for years. Infection does not occur in all humans bitten by an infected animal but is uniformly fatal when clinical disease develops. After a prodrome of fever, headache, malaise, seizures, and behavioral abnormalities, hydrophobia and aerophobia supervene. Coma and death occur in 1 to several weeks. Once symptoms start, treatment is ineffective. In southern Vietnam, a viral encephalitis that was caused by avian influenza A (H5N1) and did not involve the respiratory tract was diagnosed in 2 siblings: a 4-year-old boy, who presented with severe diarrhea, seizures, coma, and death, and his sister. [35] The boy’s cerebrospinal fluid (CSF) revealed only high protein levels, but H5N1 was isolated from CSF, fecal, throat, and serum specimens. Newborns from mothers infected by Zika virus early during pregnancy exhibit higher risk of developping microcephaly and other several forms of CNS disease.

Physical Examination

Findings from physical examination are not usually diagnostic. Focal neurologic deficits (eg, opisthotonos, pareses, tremors, ataxia, hypotonia, diplopia), accentuated reflexes, and extensor plantar responses may be observed. Abnormal movements and, rarely, tremor may be seen. Increased intracranial pressure (ICP) can also lead to papilledema and cranial nerve VI palsy. Findings associated with specific viral infections A minority of patients with arbovirus infections develop acute encephalitis (or encephalomyelitis), meningitis, or a combination of both. Focal signs are only occasionally prominent in arboviral encephalitis. Patients may also have evidence of spinal cord involvement. JE can cause marked extrapyramidal manifestations, such as dull masklike face with wide staring eyes, tremor, choreoathetosis, head nodding, and rigidity. Flaccid paralysis, especially involving the lower extremities, has been described as being due to damage to the anterior horn cells. Parkinsonism can be a sequela of JE, and von Economo encephalitis (encephalitis lethargica) is considered to be a sequela of influenza encephalitis. Enterovirus 71 can cause rhombencephalitis with myoclonus, tremor, ataxia, cranial nerve involvement, neurogenic pulmonary edema, and coma. Nipah virus, in addition to the classical encephalitis presentation, produces cerebellar and brainstem signs, as well as segmental myoclonus, significant hypertension, and tachycardia. Encephalitis delayed 4 months after exposure to the virus has been described, suggesting similarities to the subacute sclerosing panencephalitis (SSPE) phenotype. Microcephaly may be seen in newborns from mothers infected by Zika virus early during pregnancy.

Complications

Secondary bacterial infections of the respiratory and urinary tracts are major complications of encephalitis. Complications depend on the severity of the encephalitis and generally decline in importance as the acute illness passes. With recovery from acute viral encephalitis, evidence of neuronal injury and death becomes apparent as residual neurologic defects, impairment of intelligence, and psychiatric disturbances. The severity of these sequelae varies according to the causative virus. [36, 37, 29, 38] Sequelae occur in 30-40% of patients aged 5-40 years and include extrapyramidal features (especially dystonia and occasionally parkinsonism), weakness, and seizure disorders. Sequelae are reported in only 3-10% of cases of JE in Japan. Yet 25-30% of young adult males serving in the armed forces of the United States during World War II had sequelae (including neuroses) 6 months after infection. In addition, 10 of 25 individuals who had JE in Guam in 1948 had neurological or intellectual defects 10 years later. Hyponatremia due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) may be frequent in St Louis encephalitis. Dehydration, respiratory complications, nosocomial infections, and decubitus ulcers may also occur.


Diagnostic Considerations

See the following for complete information on these topics:


Other conditions to be considered include the following:

  • Myoclonus

  • Partial seizures with secondary generalization

  • Seizure, partial (focal)

  • Benign epilepsy syndromes

  • Pseudomigraine with CSF pleocytosis


Differential Diagnoses

Workup

Approach Considerations Usually, general laboratory studies are not helpful, except for identifying a viral infectious process (eg, a lymphocytic predominance in the complete blood count [CBC], rather than the polymorphonuclear predominance indicative of bacterial infection). The diagnostic evaluation should include a CBC, tests of renal and hepatic function, coagulation studies, and chest radiography. During epidemics, viral encephalitis is diagnosed readily on clinical grounds. However, sporadic cases of viral encephalitis are often difficult to distinguish from other febrile illnesses (eg, gastroenteritis with dehydration and convulsions) or from intoxication. Although specific treatment for most causes of viral encephalitis is still not available, establishing the final diagnosis is important to avoid unnecessary treatments with potential side effects. [39] In most instances, the currently available specific laboratory tests only help provide a retrospective diagnosis. Serologic tests depend on the occurrence of a rise in antibody titer. However, the early detection of specific immunoglobulin M (IgM) antibody may assist early diagnosis. Analysis of cerebrospinal fluid (CSF), including polymerase chain reaction (PCR) testing, plays an important role. Reliance on magnetic resonance imaging (MRI) findings to make the diagnosis of encephalitis or to distinguish among the different viral etiologies is usually not advisable.

Blood and Skin Cultures All patients with encephalitis should have blood cultures to rule out bacterial and fungal infections. Specific clinical findings should also guide the evaluation of other sites for culture (scraping of vesicles, sputum, nasopharynx, and stool). For most arboviral infections, the viremia is usually of low magnitude and short duration, so blood viral cultures are low yield tests most of the time. Skin biopsies may be useful for diagnosis conditions such as Rocky Mountain spotted fever, and full-thickness skin biopsy from the neck with staining of sensory axons may be useful for the diagnosis of rabies. Viral cultures from throat, stool samples, and antigen detection for herpes and respiratory viruses are recommended during the first week.

Serologic Tests Some causes of encephalitis can be diagnosed by detecting serum IgM antibodies (varicella and arboviruses). Currently, IgM and immunoglobulin G (IgG) capture enzyme linked immunosorbent assays (ELISAs) are the most useful and most widely used tests for the diagnosis of arboviral encephalitis. However, there is significant cross-reactivity among flaviviruses (Japanese encephalitis virus, St Louis encephalitis virus, and West Nile virus). Anti-West Nile virus IgM is detectable in CS) and serum 10 days after infection onset. A PCR-based test for rapid detection of West Nile virus has been developed in California. A diagnosis of Japanese encephalitis (JE) can be confirmed serologically with demonstration of IgM in the CSF (sensitivity and specificity >95%). The PCR test may detect the virus within 2 days, but its reliability is uncertain. ELISAs for detection of dengue virus IgM and IgG are available for serum and CSF. [40] Antibodies to Borrelia burgdorferi and serologic testing for Rickettsia, Ehrlichia, and Anaplasma species should be checked in all patients coming from endemic areas. Blood from the acute phase should be saved for future comparisons with the titers from the convalescent phase. Despite all major efforts, in a recent study from Spain, a significant number of cases of aseptic CNS infection (42.9% meningitis, 59.3% meningoencephalitis, 72.4% encephalitis) may still have no etiological diagnosis. [41]

Analysis of Cerebrospinal Fluid Lumbar puncture Lumbar puncture should be performed immediately once a space-occupying lesion is ruled out. CSF examination is critical to establish the diagnosis and reveals, acutely, a typical viral profile: mildly to moderately elevated protein (60-80 mg/dL), normal glucose, and a moderate pleocytosis (up to 1000 leukocytes/µL). Mononuclear cells usually predominate, though early in fulminant encephalitis, polymorphonuclear leukocytes predominate. Persistent neutrophilic pleocytosis can occur in patients with West Nile encephalitis (WNE). Viral cultures are rarely helpful for acute management. Findings from CSF cultures for enteroviruses, mumps, and certain arboviruses may be positive. Low CSF glucose is unusual with viral encephalitis and suggests infection by bacteria, fungal agents, or tuberculosis. Herpes simplex encephalitis (HSE), as well as other forms of hemorrhagic encephalitis, may be associated with increased red blood cells (RBCs) and xanthochromia in the CSF. The fluid should be sent for PCR evaluation to detect herpes simplex virus (HSV) DNA; PCR is highly specific and remains positive for as long as 5 days after initiation of treatment (see below). Intrathecal antibodies can also be quantified. Eosinophils can be present in infections with helminths, Treponema pallidum, Mycoplasma pneumoniae, Rickettsia rickettsii, Coccidioides immitis, and Toxoplasma gondii. They can be mistaken for neutrophils if cell count is done in automated cell counters or can be easily destroyed or distorted during processing. Up to 10% of the patients with viral encephalitis may have completely normal CSF studies. CSF findings in patients with acute disseminated encephalomyelitis (ADEM) are similar to those in patients with viral encephalitis, but pleocytosis is less marked or absent, and markers of intrathecal immunoglobulin synthesis may be present (less than in multiple sclerosis). Polymerase chain reaction PCR testing should be performed to detect viral nucleic acid in CSF. In undiagnosed cases, PCR should be repeated after 3-7 days, and blood tests should be performed after 2-4 weeks to show possible seroconversion or diagnostic increase in antibody levels. PCR is especially useful for infections caused by herpesviruses and enteroviruses. In infants and neonates, the sensitivity and specificity for CSF PCR for HSV are more variable. In adults, the test may initially yield negative results, especially if the white blood cell (WBC) count in the CSF is lower than 10/µL. Results may turn positive 1-3 days after initiation of treatment. PCR can also detect varicella-zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV), JC virus, and West Nile virus (positive in < 60% serologically confirmed cases). Molecular testing of the saliva may establish the diagnosis of rabies. PCR testing may also be important for the diagnosis of nonviral encephalitis (as in ehrlichiosis and Bartonella henselae infection).

Computed Tomography and Positron Emission Tomography In HSV encephalitis, computed tomography (CT) scanning may show low-density lesions in the temporal lobes, which may not be present until 3-4 days after onset. Edema and hemorrhages may be found, and, after 1 week, contrast enhancement may be observed. CT findings are usually not helpful in differentiating the different viral encephalitides. However, given its low cost and its ready availability in most institutions, CT scanning may be a good choice for evaluating acute disease progression and following up on complications. It scan can readily reveal important complications (eg, hemorrhage, hydrocephalus, and herniation) and can help guide neurosurgical interventions. Positron emission tomography (PET) scanning may be useful for the evaluation of possible paraneoplastic disorders.

Magnetic Resonance Imaging Relying on MRI findings to make the diagnosis of encephalitis or to distinguish among the different viral etiologies is usually not advisable. MRI is more sensitive and specific than CT for identifying viral encephalitides, especially in the early phase. Diffusion-weighted imaging may be useful for the early diagnosis of HSV, enterovirus 71, and West Nile virus infections. In HSE, MRI typically shows temporal lobe lesions, which may be hemorrhagic and unilateral or bilateral. Inferomedial temporal lobe and cingulate gyrus are the areas most commonly detected by MRI. In children and infants, a more widespread pattern may be observed. MRI may help in differentiating Japanese encephalitis (JE) from Nipah virus encephalitis. JE is characterized by gray matter involvement, whereas Nipah virus encephalitis is associated with multiple, small, white matter lesions. With flavivirus encephalitis and eastern equine encephalitis (EEE), MRI may show mixed intense or hypointense lesions in the thalamus, basal ganglia, and midbrain, being hyperintense on fluid attenuated inversion recovery (FLAIR) and T2. The rhombencephalitis caused by enterovirus 71 can be visualized by T2-weighted MRI, which shows hyperintense signals in the brainstem. A peculiar MRI pattern on diffusion-weighted imaging and magnetic resonance spectroscopy has been described in an acute and rapid form of subacute sclerosing panencephalitis (SSPE). [42]

Electroencephalography In HSE, electroencephalography (EEG) shows abnormalities in four fifths of biopsy-proven cases. Focal temporal changes, diffuse slowing, and periodic complexes and periodic lateralizing epileptiform discharges (PLEDs) are commonly described. Frontal slowing and occasional frontal spikes have been described in encephalitis associated with influenza virus. JE is commonly associated with 3 EEG patterns: (1) diffuse continuous delta activity, (2) diffuse delta activity with spikes, and (3) alpha coma pattern. In 1 study, the EEG pattern did not correlate with the Glasgow Coma Scale score and outcome. [43] In St Louis encephalitis, EEG is characterized by diffuse delta activity, and spike and waves are not prominent in the acute stage.

Brain Biopsy Brain biopsies can yield definitive diagnosis of encephalitis, but at present they are rarely performed. A biopsy may be considered when a lumbar puncture is precluded or when the diagnosis is uncertain (eg, to rule out other conditions, such as vasculitis) and the patient’s condition is deteriorating despite treatment with acyclovir. If considered, it should be performed earlier in the course, rather than later, so that a potentially treatable condition can be identified.

Histologic Findings In acute viral encephalitis, capillary and endothelial inflammation of cortical vessels is a pathologic hallmark occurring in the gray matter or at the junction of the gray matter and white matter. Lymphocytic infiltration of the gray matter and neuronophagia may also occur. Astrocytosis and gliosis become prominent with disease progression. Some histopathologic features, such as Cowdry type A inclusion bodies in HSV infection and Negri bodies in rabies, are unique to viral infections. Arboviruses cause little histopathologic change outside the nervous system, with the possible exception of renal involvement in St Louis encephalitis. Gross examination reveals varying degrees of meningitis, cerebral edema, congestion, and hemorrhage in the brain. Microscopic examination confirms a leptomeningitis with round-cell infiltration, small hemorrhages with perivascular cuffing, and nodules of leukocytes or microglial cells. Demyelination may follow the destruction of oligodendroglias, and involvement of ependymal cells may lead to hydranencephaly. Neuronal damage is seen as chromatolysis and neuronophagia. Areas of necrosis may be extensive, especially in EEE, JE, and the Far East form of tick-borne encephalitis. In patients who survive the initial illness, varying degrees of repair are observed, which may include calcification. The pattern of distribution of lesions in the brain is rarely sufficiently specific to enable identification of the infecting virus. Generally, in EEE, the lesions are concentrated in the cortex; in western equine encephalitis (WEE), they are concentrated in the basal nuclei; and in St Louis encephalitis, they are concentrated in the substantia nigra, thalamus, pons, cerebellum, cortex, bulb, and anterior horn cells. HSE in infants is usually part of a widespread infection that produces focal necrotic lesions with typical intranuclear inclusions in many organs. In adults and in some children, lesions are confined to the brain. Necrotic foci may be macroscopically evident as softening. Hemorrhage and Cowdry type A inclusions bodies are found readily in the margins of areas of necrosis. Herpesviruses have tropism for the temporal cortex and pons, but the lesions may be widespread. Rabies virus tends to exhibit a tropism for the temporal lobes, affecting the Ammon horns. Autopsy studies in individuals with West Nile virus have shown particular brainstem involvement, especially the medulla, with endoneural mononuclear inflammation of cranial nerve roots.


Treatment & Management

Approach Considerations Medical care should be devoted to appropriate management of the airway, bladder function, fluid and electrolyte balance, nutrition, prevention of bedsores, secondary pulmonary infection, and hyperpyrexia. A multidisciplinary approach must be instituted as early as possible to start physical and cognitive rehabilitation and to minimize cognitive problems and long-term sequelae. Care in an intensive care unit (ICU) setting may be required, especially if seizure activity or increased intracranial pressure (ICP) is present. [44] Delayed diagnosis of herpes simplex encephalitis (HSE) increases morbidity and mortality rates; failure to diagnose and treat early could result in litigation. With the wide availability of effective therapy, initiating antiviral treatment before a definitive diagnosis of HSE encephalitis (ie, during the workup) is now common practice. The use of corticosteroids as an adjunctive therapy for viral encephalitis is controversial and currently being evaluated in a large clinical trial. Recent promising therapies with recombinant fully humanized antibody against Nipah and Hendra virus have been tested in experimental animals and in a compassionate basis in humans. See the following for complete information on these topics:


Antiviral Therapy Pharmacotherapy for HSE consists of acyclovir and vidarabine. Outcome is improved with either agent, but acyclovir is more effective and less toxic. Even if the final diagnosis of HSE has not been established, intravenous (IV) acyclovir should be initiated immediately. Acyclovir is also the drug of choice for varicella-zoster virus (VZV) encephalitis, although ganciclovir is also considered an alternative option. Ganciclovir has been used for cytomegalovirus (CMV) encephalitis, but with therapeutic failures; consequently, the optimal therapy for CMV encephalitis is unknown. Ganciclovir combined with foscarnet has been used in the treatment of patients infected with HIV. No specific treatment is available for the arbovirus encephalitides. Ribavirin seems to be effective for Lassa fever; its efficacy in other viral infections is being evaluated. Intraventricular ribavirin has been associated with clinical improvement in 4 patients with subacute sclerosing panencephalitis (SSPE) and apparently reduced mortality in an open-label trial in patients with Nipah virus encephalitis. Results from a small series suggested that interferon alfa-2b reduced the severity and duration of the complications of St Louis encephalitis virus meningoencephalitis. [45] Because specific therapy for encephalitis is limited and because potentially serious sequelae (or death) may result from HSE, early treatment with acyclovir should be started as soon as possible in all patients with suspected viral encephalitis, pending the results of diagnostic studies. Once an etiologic agent of the encephalitis is eventually identified, therapy should be targeted to that agent (if available). Other antibacterial treatments (eg, for bacterial meningitis) should be administered on the basis of epidemiological and clinical factors or given until the diagnosis of bacterial meningitis is excluded. Doxycycline should be added if there is suspicion of rickettsial or ehrlichial infection during the appropriate season.

Management of Increased Intracranial Pressure Increased ICP should be managed in the ICU setting with head elevation, gentle diuresis, mannitol, and hyperventilation. Surgical decompression may be necessary if there is impending uncal herniation or increased ICP that is refractory to medical management. Controlled studies are lacking, but there is some evidence that patients with life-threatening cerebral edema may benefit from craniectomy or other approaches to lower the increased ICP in neurocritical care units. [46]

Management of Seizures Encephalitis causes a wide range of behavioral manifestations with limbic and frontal syndromes that can be difficult to distinguish from partial seizures. [47] Seizure activity can be closely observed using electroencephalography (EEG), and the threshold for administering temporary anticonvulsant therapy should be low. Phenytoin and valproic acid can be administered intravenously. Phenytoin and carbamazepine can be administered when oral or intragastric drug administration is possible. Benzodiazepines are also important when used to abort status epilepticus. If seizure activity persists after the acute phase, patients may need long-term anticonvulsant therapy. Accordingly, additional therapy may be necessary for extrapyramidal, motor, and behavioral complications.

Prevention Surveillance is important to predict outbreaks of arboviral infections. Mosquitoes can be sampled to estimate infection rates in mosquito pools. Protective clothing and repellents are useful in the prevention of arthropod bites. Avoidance of outdoor activities is also useful. Prompt removal of ticks may decrease the risk of transmission of a tick-borne virus. Effective preventive measures include removing water-holding containers and discarded tires. Insecticides may be useful in the emergency control of infected mosquitoes. Control of the mosquito vector has been used with apparently good results in several recent epidemics. Vaccines are available for eastern equine encephalitis (EEE), western equine encephalitis (WEE), and Venezuelan equine encephalitis (VEE) in horses. A live attenuated vaccine (TC-83) has been used to protect laboratory and field workers from the virus that causes VEE. Vaccines have also been developed for Japanese B virus encephalitis (JE) and tick-borne encephalitis (TBE). Killed virus vaccines have been produced experimentally for several arboviruses. A live-attenuated Japanese B vaccine (SA 14-14-2) has been used widely in Asia. Since 1989, 120 million children have been immunized, and a recent report has demonstrated the efficacy of a single dose in preventing Japanese encephalitis (JE) when administered only days or weeks before exposure to infection. The only internationally licensed JE virus vaccine is a formalin-inactivated vaccine. Limited use (eg, in exposed laboratory workers) has been made of vaccines for VEE and tick-borne viral encephalitis. Passive immunization of laboratory workers exposed to a known virus in a laboratory accident has been accomplished with immune (human) serum or gamma globulin. Despite control efforts and disease surveillance, the 1999 outbreak of West Nile virus in New York, with subsequent spread to other states in the United States, showed that different viruses may be spread in the Western hemisphere because of increased international travel and trade. Massive culling of pigs in Malaysia decreased the incidence of Nipah virus infection.

Consultations and Additional Care Encephalitis is a neurological emergency. Consultation with a neurologist is recommended. Consultation with a neurosurgeon is helpful if a brain biopsy is considered. Consultation with an infectious disease specialist is also appropriate. Given the high likelihood of long-term need for cognitive rehabilitation and physical rehabilitation, especially in moderately severe and severe forms of encephalitis, establishing a multidisciplinary approach early in the disease course is appropriate. A multidisciplinary approach includes consultations with physical, occupational, and speech therapists. No dietary restrictions are necessary. The infectious process, especially with the presence of fever, increases nutritional requirements. Early assessment by a speech therapist and a dietitian helps prevent further body wasting and detects early behavioral manifestations that prevent adequate nutritional intake, such as placidity, apraxia, dysphagia, or agitation.


Medication

Medication Summary Pharmacotherapy for herpes simplex encephalitis (HSE) consists of acyclovir and vidarabine. Outcome is improved with either agent, but acyclovir is more effective and less toxic. Even if the final diagnosis of HSE has not been established, intravenous (IV) acyclovir should be initiated immediately. Acyclovir is also the drug of choice for varicella-zoster virus (VZV) encephalitis, although ganciclovir is also considered an alternative option. Ganciclovir has been used for cytomegalovirus (CMV) encephalitis, but with therapeutic failures; optimal therapy for CMV encephalitis is unknown. Ganciclovir combined with foscarnet has been used in the treatment of patients infected with HIV. No specific treatment is available for the arbovirus encephalitides. The efficacy of ribavirin in other viral infections is being evaluated.

Antiviral Agents Class Summary Antiviral agents shorten the clinical course, prevent complications, prevent development of latency and subsequent recurrences, decrease transmission, and eliminate established latency. Acyclovir (Zovirax)

Acyclovir has demonstrated inhibitory activity against both herpes simplex virus type 1 (HSV-1) and herpes simplex virus type 2 (HSV-2) and is taken up selectively by infected cells. Before the use of acyclovir, mortality from HSE was 60-70%; since acyclovir, it has been approximately 30%. Acyclovir may also be effective for VZV encephalitis. Ribavirin (Virazole, Ribasphere)

Ribavirin is a synthetic guanosine analogue (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide) that inhibits viral replication by inhibiting DNA and RNA synthesis. It is phosphorylated in vivo, and the active form may interfere with viral genomic synthesis. Clinical experience in the treatment of arenavirus infections is primarily with Lassa fever, but anecdotal experience in South American arenaviruses also exists. Ribavirin is used clinically in combination with interferon for hepatitis C, in aerosol form for respiratory syncytial virus (RSV), and as potential prophylaxis and/or treatment of Congo-Crimean hemorrhagic fever, hantavirus infections, and arenavirus hemorrhagic fevers. In vitro evidence exists for activity against West Nile virus. The IV form of the drug is not readily available, and the manufacturer should be contacted if the need arises. Ganciclovir (Cytovene, Vitrasert)

Ganciclovir is a synthetic guanine derivative that is active against CMV. It is an acyclic nucleoside analogue of 2'-deoxyguanosine that inhibits viral replication in vitro and in vivo by competing with deoxyguanosine triphosphate for viral DNA polymerase, inhibiting DNA synthesis. Ganciclovir triphosphate levels are up to 100-fold greater in CMV-infected cells than in uninfected cells, possibly because of preferential phosphorylation in infected cells. Foscarnet (Foscavir)

Foscarnet is an organic analogue of inorganic pyrophosphate that inhibits viral replication in vitro. It exerts its antiviral activity by selective inhibition at pyrophosphate-binding sites on virus-specific DNA polymerases at concentrations that do not affect cellular DNA polymerases, inhibiting DNA synthesis. Viral resistance should be considered in patients with poor clinical response or persistent viral excretion. Patients who show excellent tolerance of foscarnet may benefit from initiation of a maintenance dosage (ie, 120 mg/kg/d) earlier in their treatment. Individualize the dosing according to the patient's renal function status. Foscarnet has been demonstrated to be effective against CMV encephalitis.

Anticonvulsant Agents Class Summary These agents prevent seizure recurrence and terminate clinical and electrical seizure activity. Phenytoin (Dilantin, Phenytek)

Phenytoin may act in the motor cortex, where it may inhibit the spread of seizure activity. The activity of brain stem centers responsible for the tonic phase of grand mal seizures may also be inhibited. Individualize the dose. Administer a larger dose before retiring if the dose cannot be divided equally. The rate of infusion must not exceed 50 mg per minute to avoid hypotension and arrhythmia. Diazepam (Valium)

Diazepam depresses all levels of the CNS (eg, limbic, reticular formation), possibly by increasing the activity of gamma-aminobutyric acid (GABA). Alternatively, lorazepam can be used when indicated. Carbamazepine (Tegretol, Carbatrol, Epitol, Equetro)

Carbamazepine is effective in treatment of complex partial seizures; it appears to act by reducing polysynaptic responses and blocking posttetanic potentiation. Once a response is attained, attempt to reduce the dose to the minimum effective level or to discontinue the drug at least once every 3 months. Valproic acid (Depakote, Depakene, Depacon, Stavzor)

Valproic acid is chemically unrelated to other drugs that treat seizure disorders. Although its mechanism of action is not established, its activity may be related to increased brain levels of gamma-aminobutyric acid (GABA) or enhanced GABA action. It also may potentiate postsynaptic GABA responses, affect potassium channels, or have a direct membrane-stabilizing effect.

Osmotic Diuretics Class Summary Mannitol is recommended by some experts to help reduce intracranial pressure. Mannitol induces diuresis, which increases serum osmotic concentration. In the brain, this causes water to flow from brain cells into vascular space, thereby decreasing intracranial pressure. Mannitol (Osmitrol, Resectisol)

Mannitol may be used to decrease intracranial pressure. It may reduce subarachnoid space pressure by creating an osmotic gradient between CSF in the arachnoid space and plasma. This agent is not for long-term use. Initially assess the patient for adequate renal function by administering a test dose of 200 mg/kg intravenously over 3-5 min. It should produce a urine flow of at least 30-50 mL per hour of urine over 2-3 hours. In children, assess for adequate renal function by administering a test dose of 200 mg/kg intravenously over 3-5 min. It should produce a urine flow of at least 1 mL/kg/h over 1-3 hours.

Vaccines, Inactivated, Viral Class Summary Several vaccines are available in the United States for individuals traveling to endemic areas or those working at biomedical facilities. Japanese encephalitis virus vaccine (Ixiaro)

Indicated for adults and children aged 2 months and older at increased risk of Japanese encephalitis virus (JEV) during travel to Asia. Tick borne encephalitis vaccine (TicoVac)

Indicated in adults and children aged 1 year and older for prevention of tick-borne encephalitis caused by Flaviviridae, including European or Western tick-borne encephalitis virus (transmitted by Ixodes ricinus), Siberian tick-borne encephalitis virus (transmitted by I persulcatus), and Far-Eastern tick-borne encephalitis virus, formerly known as Russian spring summer encephalitis virus (transmitted by I persulcatus).


References


  1. Gendelman HE, Persidsky Y. Infections of the nervous system. Lancet Neurol. 2005 Jan. 4(1):12-3. [Medline].

  2. Kennedy PG. Viral encephalitis. J Neurol. 2005 Mar. 252(3):268-72. [Medline].

  3. Wilson MR. Emerging viral infections. Curr Opin Neurol. 2013 Jun. 26(3):301-6. [Medline].

  4. CDC. Zika Virus - For Pregnant Women. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/zika/pregnancy/index.html. Accessed: February 12, 2016.

  5. Medigeshi GR, Hirsch AJ, Streblow DN, Nikolich-Zugich J, Nelson JA. West Nile virus entry requires cholesterol-rich membrane microdomains and is independent of alphavbeta3 integrin. J Virol. 2008 Jun. 82(11):5212-9. [Medline]. [Full Text].

  6. Sarkari NB, Thacker AK, Barthwal SP, et al. Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics. J Neurol. 2012 Jan. 259(1):47-57. [Medline].

  7. Zhang SY, Abel L, Casanova JL. Mendelian predisposition to herpes simplex encephalitis. Handb Clin Neurol. 2013. 112:1091-7. [Medline].

  8. Lopez W. West Nile virus in New York City. Am J Public Health. 2002 Aug. 92(8):1218-21. [Medline]. [Full Text].

  9. Mostashari F, Bunning ML, Kitsutani PT, et al. Epidemic West Nile encephalitis, New York, 1999: results of a household-based seroepidemiological survey. Lancet. 2001 Jul 28. 358(9278):261-4. [Medline].

  10. Domingues RB, Teixeira AL. Management of acute viral encephalitis in Brazil. Braz J Infect Dis. 2009 Dec. 13(6):433-9. [Medline].

  11. Muzaffar J, Venkata Krishnan P, Gupta N, Kar P. Dengue encephalitis: why we need to identify this entity in a dengue-prone region. Singapore Med J. 2006 Nov. 47(11):975-7. [Medline].

  12. Araujo FM, Araujo MS, Nogueira RM, Brilhante RS, Oliveira DN, Rocha MF. Central nervous system involvement in dengue: a study in fatal cases from a dengue endemic area. Neurology. 2012 Mar 6. 78(10):736-42. [Medline].

  13. Lindquist L, Vapalahti O. Tick-borne encephalitis. Lancet. 2008 May 31. 371(9627):1861-71. [Medline].

  14. Piantadosi A, Rubin DB, McQuillen DP, Hsu L, Lederer PA, Ashbaugh CD, et al. Emerging Cases of Powassan Virus Encephalitis in New England: Clinical Presentation, Imaging, and Review of the Literature. Clin Infect Dis. 2015 Dec 13. [Medline].

  15. Sokol DK, Kleiman MB, Garg BP. LaCrosse viral encephalitis mimics herpes simplex viral encephalitis. Pediatr Neurol. 2001 Nov. 25(5):413-5. [Medline].

  16. Hsu VP, Hossain MJ, Parashar UD, et al. Nipah virus encephalitis reemergence, Bangladesh. Emerg Infect Dis. 2004 Dec. 10(12):2082-7. [Medline]. [Full Text].

  17. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. Non-Polio Enterovirus. Centers for Disease Control and Prevention. Available at http://www.cdc.gov/non-polio-enterovirus/about/ev-d68.html. March 23, 2015; Accessed: February 18, 2016.

  18. Xiang Z, Liu L, Lei X, Zhou Z, He B, Wang J. 3C Protease of Enterovirus D68 Inhibits Cellular Defense Mediated by Interferon Regulatory Factor 7. J Virol. 2015 Nov 25. 90 (3):1613-21. [Medline].

  19. Casolari S, Briganti E, Zanotti M, et al. A fatal case of encephalitis associated with Chikungunya virus infection. Scand J Infect Dis. 2008. 40(11-12):995-6. [Medline].

  20. John TJ. Chandipura virus, encephalitis, and epidemic brain attack in India. Lancet. 2004 Dec 18-31. 364(9452):2175; author reply 2175-6. [Medline].

  21. CDC. Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses — Brazil, 2015. Morbidity and Mortality Weekly Report (MMWR). February 10, 2016. Available at http://www.cdc.gov/mmwr/volumes/65/wr/mm6506e1er.htm.

  22. Sejvar JJ. The evolving epidemiology of viral encephalitis. Curr Opin Neurol. 2006 Aug. 19(4):350-7. [Medline].

  23. Rantalaiho T, Farkkila M, Vaheri A, Koskiniemi M. Acute encephalitis from 1967 to 1991. J Neurol Sci. 2001 Mar 1. 184(2):169-77. [Medline].

  24. Parisi SG, Basso M, Del Vecchio C, Andreis S, Franchin E, Dal Bello F, et al. Viral infections of the central nervous system in elderly patients: a retrospective study. Int J Infect Dis. 2016 Jan 25. [Medline].

  25. Kullnat MW, Morse RP. Choreoathetosis after herpes simplex encephalitis with basal ganglia involvement on MRI. Pediatrics. 2008 Apr. 121(4):e1003-7. [Medline].

  26. Rautonen J, Koskiniemi M, Vaheri A. Prognostic factors in childhood acute encephalitis. Pediatr Infect Dis J. 1991 Jun. 10(6):441-6. [Medline].

  27. Lancman ME, Morris HH 3rd. Epilepsy after central nervous system infection: clinical characteristics and outcome after epilepsy surgery. Epilepsy Res. 1996 Nov. 25(3):285-90. [Medline].

  28. Misra UK, Tan CT, Kalita J. Viral encephalitis and epilepsy. Epilepsia. 2008 Aug. 49 Suppl 6:13-8. [Medline].

  29. Sato S, Kumada S, Koji T, Okaniwa M. Reversible frontal lobe syndrome associated with influenza virus infection in children. Pediatr Neurol. 2000 Apr. 22(4):318-21. [Medline].

  30. Webster RI, Hazelton B, Suleiman J, Macartney K, Kesson A, Dale RC. Severe encephalopathy with swine origin influenza A H1N1 infection in childhood: case reports. Neurology. 2010 Mar 30. 74(13):1077-8. [Medline].

  31. Davis LE, DeBiasi R, Goade DE, et al. West Nile virus neuroinvasive disease. Ann Neurol. 2006 Sep. 60(3):286-300. [Medline].

  32. Debiasi RL, Tyler KL. West Nile virus meningoencephalitis. Nat Clin Pract Neurol. 2006 May. 2(5):264-75. [Medline].

  33. Sejvar JJ, Davis LE, Szabados E, Jackson AC. Delayed-onset and recurrent limb weakness associated with West Nile virus infection. J Neurovirol. 2010 Feb. 16(1):93-100. [Medline].

  34. Kumar R, Tripathi S, Tambe JJ, Arora V, Srivastava A, Nag VL. Dengue encephalopathy in children in Northern India: clinical features and comparison with non dengue. J Neurol Sci. 2008 Jun 15. 269(1-2):41-8. [Medline].

  35. de Jong MD, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med. 2005 Feb 17. 352(7):686-91. [Medline].

  36. Jang H, Boltz D, Sturm-Ramirez K, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci U S A. 2009 Aug 18. 106(33):14063-8. [Medline]. [Full Text].

  37. Ng BY, Lim CC, Yeoh A, Lee WL. Neuropsychiatric sequelae of Nipah virus encephalitis. J Neuropsychiatry Clin Neurosci. 2004 Fall. 16(4):500-4. [Medline].

  38. Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet. 2000 Mar 25. 355(9209):1053-9. [Medline].

  39. Steiner I, Budka H, Chaudhuri A, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol. 2010 Aug. 17(8):999-e57. [Medline].

  40. Puccioni-Sohler M, Soares CN, Papaiz-Alvarenga R, Castro MJ, Faria LC, Peralta JM. Neurologic dengue manifestations associated with intrathecal specific immune response. Neurology. 2009 Oct 27. 73(17):1413-7. [Medline].

  41. de Ory F, Avellon A, Echevarría JE, Sanchez-Seco MP, Trallero G, Cabrerizo M. Viral infections of the central nervous system in Spain: a prospective study. J Med Virol. 2013 Mar. 85(3):554-62. [Medline].

  42. Oguz KK, Celebi A, Anlar B. MR imaging, diffusion-weighted imaging and MR spectroscopy findings in acute rapidly progressive subacute sclerosing panencephalitis. Brain Dev. 2007 Jun. 29(5):306-11. [Medline].

  43. Kalita J, Misra UK. EEG in Japanese encephalitis: a clinico-radiological correlation. Electroencephalogr Clin Neurophysiol. 1998 Mar. 106(3):238-43. [Medline].

  44. Tunkel AR, Glaser CA, Bloch KC, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008 Aug 1. 47(3):303-27. [Medline].

  45. Rahal JJ, Anderson J, Rosenberg C, Reagan T, Thompson LL. Effect of interferon-alpha2b therapy on St. Louis viral meningoencephalitis: clinical and laboratory results of a pilot study. J Infect Dis. 2004 Sep 15. 190(6):1084-7. [Medline].

  46. Hall WA, Truwit CL. The surgical management of infections involving the cerebrum. Neurosurgery. 2008 Feb. 62 Suppl 2:519-530; discussion 530-1. [Medline].

  47. Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT. The risk of unprovoked seizures after encephalitis and meningitis. Neurology. 1988 Sep. 38(9):1407-10. [Medline].

  48. Guillaume Le Flohic, Vincent Porphyre, Philippe Barbazan, Jean-Paul Gonzalez. Review of Climate, Landscape, and Viral Genetics as Drivers of the Japanese Encephalitis Virus Ecology. PLOS Neglected Tropical Diseases. 2013. 7:e2208.

  49. Guillaume Le Flohic, Vincent Porphyre, Philippe Barbazan, Jean-Paul Gonzalez. Review of Climate, Landscape, and Viral Genetics as Drivers of the Japanese Encephalitis Virus Ecology. PLOS Neglected Tropical Diseases. 2013. 7:e2208.

  50. Lyons J, McArthur J. Emerging Infections of the Central Nervous System. Curr Infect Dis Rep. 2013 Oct 18. [Medline].

  51. Michael R. Wilson. Emerging viral infections. Current Opinion in Neurology. 2013. 26:301-306.

  52. Remi N Charrel, Laurence Bichaud, Xavier de Lamballerie. Emergence of Toscana virus in the mediterranean area. World J Virol. 2012. 1:135-141.

  53. Tsai CK, Lai YH, Yang FC, Chen CY, Peng GS. Clinical and radiologic manifestations of H1N1 virus infection associated with neurological complications: a case report. Neurologist. 2011 Jul. 17(4):228-31. [Medline].

  54. Singh TD, Fugate JE, Hocker S, Wijdicks EF, Aksamit AJ Jr, Rabinstein AA. Predictors of outcome in HSV encephalitis. J Neurol. 2015 Nov 14. [Medline].

  55. Staples JE, Dziuban EJ, Fischer M, Cragan JD, Rasmussen SA, Cannon MJ, et al. Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. MMWR Morb Mortal Wkly Rep. 2016 Jan 29. 65 (3):63-7. [Medline].


Etiquetas:

Kommentare

Entradas destacadas
Entradas recientes
Archivo
Buscar por tags
Síguenos
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square
bottom of page